Hypotensive Hemostasis in Patients Presenting with Ruptured Aortic Aneurysm
Substance and pharmacokinetic mechanism of action Primary pharmacodynamic mechanism of action Half-life Dosage repetitive i.v. bolus Dosage of continuous i.v. infusion Esmolol-specific antagonist at adrenergic β1-receptor Decrease of cardiac chrono-…